|
C19ORF70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.463600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.905800E-01 |
| Normal-vs-Stage2 |
1.506980E-01 |
| Normal-vs-Stage3 |
9.581200E-01 |
| Normal-vs-Stage4 |
1.492650E-01 |
| Stage1-vs-Stage2 |
2.230100E-02 |
| Stage1-vs-Stage3 |
3.161600E-01 |
| Stage1-vs-Stage4 |
2.544000E-01 |
| Stage2-vs-Stage3 |
8.611900E-02 |
| Stage2-vs-Stage4 |
6.422800E-03 |
| Stage3-vs-Stage4 |
8.860000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.375600E-01 |
| Normal-vs-AfricanAmerican |
3.622200E-01 |
| Normal-vs-Asian |
5.328400E-01 |
| Caucasian-vs-AfricanAmerican |
6.718600E-01 |
| Caucasian-vs-Asian |
9.046000E-01 |
| AfricanAmerican-vs-Asian |
6.338200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.904200E-01 |
| Normal-vs-Female |
6.135600E-01 |
| Male-vs-Female |
7.690800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.081600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.511800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.307400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.332200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.950800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.468170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.203000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.612010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.486600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.381000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.385200E-01 |
| Classical-VS-Follicular |
3.43229999977268E-07 |
| Classical-VS-Other |
5.461200E-01 |
| Classical-VS-Normal |
7.193700E-02 |
| Tall-VS-Follicular |
1.057540E-02 |
| Tall-VS-Other |
7.936400E-01 |
| Tall-VS-Normal |
5.157200E-01 |
| Follicular-VS-Other |
2.448000E-01 |
| Follicular-VS-Normal |
2.568200E-02 |
| Other-VS-Normal |
8.916400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.210200E-01 |
| Normal-vs-N1 |
5.835400E-01 |
| N0-vs-N1 |
1.362840E-01 |
|
|
